• Leahy, making sure that the government does not have to disclose any information under the Freedom of Information Act relating to drug inspections from a foreign government agency;

• Sen. Rob PortmanRob PortmanFive takeaways from the CBO score on Senate ObamaCare bill McConnell allies confident in healthcare win GOP’s message on ObamaCare is us versus them MORE (R-Ohio), directing the attorney general to establish uniform standards for the exchange of controlled substance and prescription information for the purpose of preventing diversion, fraud and abuse of controlled substances and other prescription drugs; and,

• Sen. Tom CoburnTom Coburn'Path of least resistance' problematic for Congress Freedom Caucus saved Paul Ryan's job: GOP has promises to keep Don't be fooled: Carper and Norton don't fight for DC MORE (R-Okla.), to require an independent assessment of the FDA's review of drug applications.

ADVERTISEMENT
Also by unanimous consent, the Senate approved an amendment from Portman to place synthetic drugs on Schedule I of the Controlled Substances Act.

Harkin also announced that another amendment from Coburn would be withdrawn — a proposal to require the Health and Human Services secretary to ensure that performance awards are connected to employee evaluations.

Senate Majority Leader Harry ReidHarry ReidCharles Koch thanks Harry Reid for helping his book sales Warren cautions Dems against infighting Dems see surge of new candidates MORE (D-Nev.) said Thursday morning that he hoped some of the remaining 11 amendments to the FDA bill could be handled quickly. With the four unanimous consent votes, seven roll-call votes remain before final passage. These votes are scheduled for 2 p.m., but Reid said he hoped they might start earlier.